Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novanta Inc. - Common Shares (NQ:NOVT)

128.65 +9.83 (+8.27%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Novanta Inc. - Common Shares

< Previous 1 2 3 4 Next >
Why Is Novanta (NOVT) Stock Rocketing Higher Today
Shares of medicine and manufacturing technology provider Novanta (NASDAQ:NOVT) jumped 8% in the afternoon session after an analyst at William Blair gave the company a Buy rating. The analyst, Brian... 
Via StockStory
Topics Artificial Intelligence Economy
2 Cash-Producing Stocks for Long-Term Investors and 1 We Question
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
3 Reasons to Sell NOVT and 1 Stock to Buy Instead
Over the past six months, Novanta’s stock price fell to $105.42. Shareholders have lost 5% of their capital, which is disappointing considering the S&P 500 has climbed by 27.9%. This was partly driven... 
Via StockStory
Topics Government Stocks World Trade
Thermon, Novanta, Curtiss-Wright, Hillenbrand, and Helios Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after investors grew anxious as the U.S. government shutdown extended into its seventh day, creating widespread uncertainty. 
Via StockStory
Topics Economy
Earnings Scheduled For August 5, 2025
 
Via Benzinga
Earnings Scheduled For May 6, 2025
 
Via Benzinga
Unpacking Q2 Earnings: Belden (NYSE:BDC) In The Context Of Other Electronic Components Stocks
Let’s dig into the relative performance of Belden (NYSE:BDC) and its peers as we unravel the now-completed Q2 electronic components earnings season. 
Via StockStory
Plug Power, Powell, Novanta, Vishay Precision, and Concrete Pumping Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after investors scooped up equities, shaking off the initial concerns inferred from the Fed's dot plot, with tech stocks leading the charge. 
Via StockStory
Topics Bonds Economy
Electronic Components Stocks Q2 Highlights: Novanta (NASDAQ:NOVT)
Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Novanta (NASDAQ:NOVT) and its peers. 
Via StockStory
3 Profitable Stocks We Keep Off Our Radar
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential. 
Via StockStory
Electronic Components Stocks Q2 Earnings Review: Bel Fuse (NASDAQ:BELFA) Shines
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at electronic components stocks, starting... 
Via StockStory
3 Industrials Stocks That Fall Short
Whether you see them or not, industrials businesses play a crucial part in our daily activities. They are also bound to benefit from a friendlier regulatory environment with the Trump administration,... 
Via StockStory
Topics Government Stocks
Astronics, nLIGHT, Kadant, Montrose, and Novanta Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after an unexpectedly sharp rise in wholesale inflation fueled concerns about rising costs and their impact on corporate profits. The primary catalyst... 
Via StockStory
Topics Artificial Intelligence Economy World Trade
NOVT Q2 Deep Dive: Medical Device Growth Offset by Guidance Caution and Trade Uncertainty
Medicine and manufacturing technology provider Novanta (NASDAQ:NOVT) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 2.2% year on year to $241 million. On the other hand, next... 
Via StockStory
Topics World Trade
Novanta (NOVT) Q2 Revenue Rises 2.2%
Via The Motley Fool
Topics Economy
Novanta’s (NASDAQ:NOVT) Q2: Beats On Revenue But Quarterly Revenue Guidance Misses Expectations
Medicine and manufacturing technology provider Novanta (NASDAQ:NOVT) announced better-than-expected revenue in Q2 CY2025, with sales up 2.2% year on year to $241 million. On the other hand, next... 
Via StockStory
Novanta (NOVT) Q2 Earnings Report Preview: What To Look For
Medicine and manufacturing technology provider Novanta (NASDAQ:NOVT) will be reporting earnings this Tuesday before market open. Here’s what to expect. 
Via StockStory
3 Cash-Producing Stocks Facing Headwinds
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
3 Profitable Stocks Walking a Fine Line
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. 
Via StockStory
3 Industrials Stocks Facing Headwinds
Industrials businesses quietly power the physical things we depend on, from cars and homes to e-commerce infrastructure. But they are at the whim of volatile macroeconomic factors that influence... 
Via StockStory
Topics Economy Stocks
Q1 Earnings Outperformers: Novanta (NASDAQ:NOVT) And The Rest Of The Electronic Components Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at Novanta (NASDAQ:NOVT) and its peers. 
Via StockStory
NOVT Q1 Earnings Call: Resilient Performance Amid Trade Headwinds and Strategic Acquisition
Medicine and manufacturing technology provider Novanta (NASDAQ:NOVT) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 1.1% year on year to $233.4 million. On the other hand, next... 
Via StockStory
Topics World Trade
Novanta’s (NASDAQ:NOVT) Q1 Earnings Results: Revenue In Line With Expectations But Stock Drops 12.3%
Medicine and manufacturing technology provider Novanta (NASDAQ:NOVT) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 1.1% year on year to $233.4 million. On the other hand, next... 
Via StockStory
Novanta (NOVT) Q1 Earnings Report Preview: What To Look For
Medicine and manufacturing technology provider Novanta (NASDAQ:NOVT) will be announcing earnings results tomorrow before the bell. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence
3 Small-Cap Stocks with Questionable Fundamentals
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a... 
Via StockStory
Topics Economy Supply Chain
Reflecting On Electronic Components Stocks’ Q4 Earnings: Novanta (NASDAQ:NOVT)
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the electronic components stocks, including Novanta (NASDAQ:NOVT) and its peers. 
Via StockStory
Electronic Components Stocks Q4 Recap: Benchmarking Vishay Precision (NYSE:VPG)
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at electronic components stocks, starting... 
Via StockStory
3 Reasons NOVT is Risky and 1 Stock to Buy Instead
Novanta’s stock price has taken a beating over the past six months, shedding 21.9% of its value and falling to a new 52-week low of $133.58 per share. This was partly due to its softer quarterly... 
Via StockStory
Reasonable Growth, Debt Levels, and a High ROIC Make NOVANTA INC (NASDAQ:NOVT) Appealing to Quality Investors.
A fundamental analysis of (NASDAQ:NOVT) shows NOVANTA INC (NASDAQ:NOVT) may be suited for quality investing, we'll explore why in this article. 
Via Chartmill
2 High-Flying Stocks to Own for Decades and 1 to Brush Off
"You get what you pay for" often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated... 
Via StockStory
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.